Anadys Pharmaceuticals
United States
series-c-plus
series-c-plus
Stage
About
Anadys Pharmaceuticals was a US biopharmaceutical company focused on developing antiviral therapeutics. The company was listed on NASDAQ in 2004.
Explore Anadys Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.